Abstract:Although the use of bioresorbable materials in stent production is thought to improve long-term safety compared to their durable counterparts, a recent FDA report on the 2-year follow-up of the first FDA-approved bioresorbable vascular stent showed an increased occurrence of major adverse cardiac events and thrombosis in comparison to the metallic control. In order to overcome the issues of first generation bioresorbable polymers, a series of polyethylene glycol-functionalized poly-L-lactide-co-ε-caprolactone copolymers with varying lactide-to-caprolactone content is developed using a novel one-step PEG-functionalization and copolymerization strategy. This approach represents a new facile way toward surface enhancement for cellular interaction, which is shown by screening these materials regarding their cyto- and hemocompatibility in terms of cytotoxicity, hemolysis, platelet adhesion, leucocyte activation and endothelial cell adhesion. By varying the lactide-to-caprolactone polymer composition, it is possible to gradually affect endothelial and platelet adhesion which allows fine-tuning of the biological response based on polymer chemistry. All polymers developed were non-cytotoxic, had acceptable leucocyte activation levels and presented non-hemolytic (<2% hemolysis rate) behavior except for PLCL-PEG 55:45 which presented hemolysis rate of 2.5% ± 0.5. Water contact angles were reduced in the polymers containing PEG functionalization (PLLA-PEG: 69.8° ± 2.3, PCL-PEG: 61.2° ± 7.5) versus those without (PLLA: 79.5° ± 3.2, PCL: 76.4° ± 10.2) while the materials PCL-PEG550, PLCL-PEG550 90:10 and PLCL-PEG550 70:30 demonstrated best endothelial cell adhesion. PLLA-PEG550 and PLCL-PEG550 70:30 presented as best candidates for cardiovascular implant use from a cytocompatibility perspective across the spectrum of testing completed. Altogether, these polymers are excellent innovative materials suited for an application in stent manufacture due to the ease in translation of this one-step synthesis strategy to device production and their excellent in vitro cyto- and hemocompatibility.

Biosynthetic Plastics as Tunable Elastic and Visible Stent with Shape‐Memory to Treat Biliary Stricture (Adv. Sci. 29/2023)

Biosynthetic Plastics as Tunable Elastic and Visible Stent with Shape‐Memory to Treat Biliary Stricture

Biliary stents for active materials and surface modification: Recent advances and future perspectives

Design of novel poly(L-lactide)-based shape memory multiblock copolymers for biodegradable esophageal stent application

Towards a Customizable, SLA 3D-Printed Biliary Stent: Optimizing a Commercially Available Resin and Predicting Stent Behavior with Accurate In Silico Testing

Microinjection Molded Biopolymeric Airway Stent with Antibacterial and Anti-Hyperplastic Properties

The Progress of Biodegradable Biliary Stents

Cytocompatibility Evaluation of a Novel Series of PEG-Functionalized Lactide-Caprolactone Copolymer Biomaterials for Cardiovascular Applications

An Innovative Solvent‐Responsive Coiling–Expanding Stent

In vivo and in vitro evaluation of a biodegradable magnesium vascular stent designed by shape optimization strategy

A Novel Wavy Non-Uniform Ligament Chiral Stent with J-shaped Stress–strain Behavior to Mimic the Native Trachea

Study of Biodegradable and Self-Expandable PLLA Helical Biliary Stent in Vivo and in Vitro

3D‐printed shape memory poly(alkylene terephthalate) scaffolds as cardiovascular stents revealing enhanced endothelialization

In vitro degradation and biocompatibility evaluation of fully biobased thermoplastic elastomers consisting of poly(β-myrcene) and poly( -lactide) as stent coating

Hybrid interpenetrating network of polyester coronary stent with tunable biodegradation and mechanical properties

A Biodegradable Magnesium Alloy Vascular Stent Structure: Design, Optimisation and Evaluation.

3D Printing and Characterization of the Biodegradable Vascular Stent

Development of a polymer stent with shape memory effect as a drug delivery system

Bioinspired Vascular Stents with Microfluidic Electrospun Multilayer Coatings for Preventing in‐stent Restenosis

Antistricture Ureteral Stents with a Braided Composite Structure and Surface Modification with Antistenosis Drugs

Advances in the development of biodegradable coronary stents: A translational perspective